Industry, research experts surprised, disappointed at TGA’s Andrographis removal

The Australian health supplement industry has expressed disappointment at the Therapeutic Goods Administration’s (TGA) decision to remove Andrographis paniculata’s use in listed medicines, questioning why stronger, front-of-pack warnings were not implemented.